Understanding biotech investing

“As with startups, biotech companies have high failure rates: 90% of clinical programs fail to receive FDA approval, while 92% of biotech companies are unprofitable at any given time.” learn more

Leave a Reply

Your email address will not be published. Required fields are marked *